Skip to main navigation Skip to search Skip to main content

New Antimicrobial Accramycins from Streptomyces sp. MA37 Variant

  • Aziz Alabed
  • , Kwaku Kyeremeh
  • , Hai Deng*
  • *Corresponding author for this work
  • University of Ghana

Research output: Contribution to journal › Article › peer-review

5 Downloads (Pure)

Abstract

In our continued desire to isolate more bioactive compounds from the Streptomyces sp. MA37 variant, ΔaccJ, three new accramycin derivatives have been successfully characterised. The structures of accramycin L-N (1–3) were established by high-resolution mass spectrometry and 1D and 2D nuclear magnetic resonance. The antimicrobial evaluation of accramycin L-N against Staphylococcus aureus, Klebsiella pneumoniae, and Enterobacter cloacae showed minimum inhibitory concentration (MIC) values ranging from 0.77 to 13.02 µg/mL. Accramycin L exhibited the most significant activity against S. aureus. In addition, accramycin L-N (1–3) displayed significant activity against K. pneumoniae at the MIC values of 0.81, 0.77, and 0.79 µg/mL, respectively.

Original languageEnglish
Article numberM1754
Number of pages8
JournalMolBank
Volume2024
Issue number1
Early online date28 Dec 2023
DOIs
Publication statusPublished - Mar 2024

Data Availability Statement

Data are contained within the article and Supplementary Materials.

Funding

H.D. and K.K. thank the financial supports of Leverhulme Trust–Royal Society Africa award (AA090088) and the jointly funded UK Medical Research Council (MRC) and the UK Foreign, Commonwealth & Development Office (FCDO) under the MRC/FCDO Concordat agreement (MR/S00520X/1).

FundersFunder number
Leverhulme TrustAA090088
Medical Research CouncilMR/S00520X/1

    Keywords

    • accramycin
    • antimicrobial activity
    • natural product
    • polyketides
    • Streptomycessp

    Fingerprint

    Dive into the research topics of 'New Antimicrobial Accramycins from Streptomyces sp. MA37 Variant'. Together they form a unique fingerprint.

    Cite this